Ted A.W. Splinter

4.2k total citations · 1 hit paper
84 papers, 2.9k citations indexed

About

Ted A.W. Splinter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ted A.W. Splinter has authored 84 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Ted A.W. Splinter's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Ted A.W. Splinter is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Ted A.W. Splinter collaborates with scholars based in Netherlands, Belgium and United States. Ted A.W. Splinter's co-authors include Giuseppe Giaccone, Henk G. Schmidt, Jan P. van Meerbeeck, Nico van Zandwijk, C. Debruyne, Egbert F. Smit, Ate van der Gaast, G. Kramer, Vivianne C. G. Tjan‐Heijnen and Bonne Biesma and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ted A.W. Splinter

84 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer

2007 471 citations Jan P. van Meerbeeck, G. Kramer et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ted A.W. Splinter Netherlands	28	1.4k	1.2k	500	422	362	84	2.9k
R L Souhami United Kingdom	25	1.5k 1.1×	1.3k 1.1×	292 0.6×	264 0.6×	529 1.5×	53	3.0k
S. Pecorelli Italy	34	724 0.5×	1.3k 1.1×	1.8k 3.7×	514 1.2×	578 1.6×	97	6.8k
Sun Lee United States	29	487 0.4×	643 0.5×	1.2k 2.4×	194 0.5×	467 1.3×	160	3.2k
Veena Shankaran United States	27	1.6k 1.2×	3.5k 2.9×	661 1.3×	388 0.9×	747 2.1×	116	5.9k
Judith S. Kaur United States	28	550 0.4×	2.0k 1.7×	316 0.6×	522 1.2×	638 1.8×	115	3.8k
W. Gregory United Kingdom	20	468 0.3×	1.4k 1.2×	292 0.6×	749 1.8×	734 2.0×	37	3.6k
Jürg Bernhard Switzerland	35	1.2k 0.9×	2.1k 1.7×	541 1.1×	479 1.1×	169 0.5×	98	4.2k
Astra M. Liepa United States	25	968 0.7×	867 0.7×	353 0.7×	131 0.3×	279 0.8×	94	2.2k
Anna Vlahiotis United States	18	811 0.6×	1.4k 1.2×	290 0.6×	80 0.2×	512 1.4×	36	2.5k
Shari Goldfarb United States	26	387 0.3×	1.3k 1.1×	289 0.6×	473 1.1×	242 0.7×	96	3.1k

Countries citing papers authored by Ted A.W. Splinter

Since Specialization

Citations

This map shows the geographic impact of Ted A.W. Splinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted A.W. Splinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted A.W. Splinter more than expected).

Fields of papers citing papers by Ted A.W. Splinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted A.W. Splinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted A.W. Splinter. The network helps show where Ted A.W. Splinter may publish in the future.

Co-authorship network of co-authors of Ted A.W. Splinter

This figure shows the co-authorship network connecting the top 25 collaborators of Ted A.W. Splinter. A scholar is included among the top collaborators of Ted A.W. Splinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted A.W. Splinter. Ted A.W. Splinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Urlings‐Strop, Louise C., Axel P. N. Themmen, Theo Stijnen, & Ted A.W. Splinter. (2011). Selected medical students achieve better than lottery‐admitted students during clerkships. Medical Education. 45(10). 1032–1040. 29 indexed citations

Mamede, Sílvia, Henk G. Schmidt, Remy M. J. P. Rikers, et al.. (2010). Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expert. Psychological Research. 74(6). 586–592. 101 indexed citations

Urlings‐Strop, Louise C., Theo Stijnen, Axel P. N. Themmen, & Ted A.W. Splinter. (2009). Selection of medical students: a controlled experiment. Medical Education. 43(2). 175–183. 59 indexed citations

Denessen, Eddie, et al.. (2009). The clinical skills assessment for international medical graduates in The Netherlands. Medical Teacher. 31(11). e533–e538. 8 indexed citations

Meerbeeck, Jan P. van, G. Kramer, Paul Van Schil, et al.. (2007). Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 99(6). 442–450. 471 indexed citations breakdown →

Wimmers, Paul F., Henk G. Schmidt, & Ted A.W. Splinter. (2006). Influence of clerkship experiences on clinical competence. Medical Education. 40(5). 450–458. 104 indexed citations

Wimmers, Paul F., Ted A.W. Splinter, Gregory R. Hancock, & Henk G. Schmidt. (2006). Clinical Competence: General Ability or Case-specific?. Advances in Health Sciences Education. 12(3). 299–314. 26 indexed citations

Polée, M., Wim C.J. Hop, T.C. Kok, et al.. (2003). Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. British Journal of Cancer. 89(11). 2045–2050. 81 indexed citations

Giaccone, Giuseppe, Egbert F. Smit, Jan P. van Meerbeeck, et al.. (2000). A phase I–II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients. Annals of Oncology. 11(1). 109–112. 44 indexed citations

10.

Stam, Henk J., et al.. (2000). Evaluation of Diffusing Capacity in Patients With a Restrictive Lung Disease. CHEST Journal. 117(3). 752–757. 28 indexed citations

11.

Splinter, Ted A.W., M. Pavone‐Macaluso, Didier Jacqmin, et al.. (1996). Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: Prognostic factor analysis. European Journal of Cancer. 32(7). 1129–1134. 2 indexed citations

12.

Gaast, Ate van der, T.C. Kok, G.S. Kho, B. G. Blijenberg, & Ted A.W. Splinter. (1995). Disease monitoring by the tumour markers Cyfra 21.1 and TPA in patients with non-small cell lung cancer. European Journal of Cancer. 31(11). 1790–1793. 14 indexed citations

13.

Tanis, Bea C., Jan B. Vermorken, W.W. ten Bokkel Huinink, et al.. (1992). Multicenter Phase II Study of Spiroplatin. Oncology. 49(2). 99–103. 9 indexed citations

14.

Gaast, Ate van der, Wim J. Kirkels, B. G. Blijenberg, & Ted A.W. Splinter. (1992). Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract. Journal of Cancer Research and Clinical Oncology. 118(8). 626–628. 4 indexed citations

15.

Bac, D. J., T.C. Kok, Ate van der Gaast, & Ted A.W. Splinter. (1991). Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 117(3). 263–265. 9 indexed citations

16.

Gaast, Ate van der, et al.. (1990). Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer. 65(3). 422–424. 84 indexed citations

17.

Scher, Howard I. & Ted A.W. Splinter. (1990). Neoadjuvant chemotherapy for invasive bladder cancer: future directions.. PubMed. 17(5). 635–8. 4 indexed citations

18.

Oosterom, Allan T. van, Jean Pierre Droz, Aldo Bono, et al.. (1989). TCNU in advanced renal cancer. European Journal of Cancer and Clinical Oncology. 25(12). 1889–1890. 1 indexed citations

19.

Mulder, Paula O.M., Elisabeth G.E. de Vries, Heimen Schraffordt Koops, et al.. (1988). Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors. European Journal of Cancer and Clinical Oncology. 24(4). 675–679. 31 indexed citations

20.

Splinter, Ted A.W., et al.. (1985). Synchronous Presentation of Two Primary Bronchogenic Carcinomas. Respiration. 48(2). 183–187. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact